Capital International’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-22,771
Closed -$12.6M – 153
2023
Q4
$12.6M Buy
22,771
+186
+0.8% +$87.3K 0.65% 53
2023
Q3
$9.88M Sell
22,585
-195
-0.9% -$97.2K 0.57% 61
2023
Q2
$11.4M Buy
22,780
+247
+1% +$118K 0.64% 58
2023
Q1
$11.3M Buy
22,533
+925
+4% +$443K 0.68% 54
2022
Q4
$8.82M Buy
21,608
+6
+0% +$2.33K 0.61% 64
2022
Q3
$7.04M Buy
21,602
+2,977
+16% +$1.09M 0.49% 66
2022
Q2
$6.53M Hold
18,625
– – 0.49% 67
2022
Q1
$10.2M Sell
18,625
-4,441
-19% -$2.34M 0.58% 52
2021
Q4
$15.2M Buy
23,066
+82
+0.4% +$51.5K 0.77% 34
2021
Q3
$14.3M Sell
22,984
-250
-1% -$168K 0.78% 33
2021
Q2
$14.7M Buy
23,234
+2,258
+11% +$1.25M 0.81% 32
2021
Q1
$10.3M Sell
20,976
-938
-4% -$470K 0.62% 45
2020
Q4
$11M Hold
21,914
– – 0.64% 43
2020
Q3
$8.62M Buy
21,914
+2,669
+14% +$987K 0.58% 46
2020
Q2
$6.35M Buy
19,245
+310
+2% +$89.8K 0.59% 47
2020
Q1
$4.59M Buy
18,935
+120
+0.6% +$31.3K 0.51% 52
2019
Q4
$4.91M Buy
18,815
+6,020
+47% +$1.59M 0.52% 57
2019
Q3
$3.48M Buy
12,795
+6,212
+94% +$1.73M 0.53% 60
2019
Q2
$1.81M Hold
6,583
– – 0.43% 66
2019
Q1
$1.47M Hold
6,583
– – 0.35% 80
2018
Q4
$1.23M Hold
6,583
– – 0.33% 80
2018
Q3
$1.64M Sell
6,583
-499
-7% -$121K 0.51% 59
2018
Q2
$1.54M Hold
7,082
– – 0.27% 99
2018
Q1
$1.35M Hold
7,082
– – 0.24% 107
2017
Q4
$1.11M Buy
+7,082
New +$1.11M 0.21% 114

Other funds holding IDXX

Capital International's IDXX Position: Q1 2024 in Review

Capital International sold out of Idexx Laboratories (IDXX) in Q1 2024, closing a stake of 22,771 shares — an estimated $12.6M sold.

Capital International first reported a position in IDXX in Q4 2017 and held it in 25 quarters. The position peaked at $15.2M in Q4 2021. 1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

  • Capital International reported no remaining Idexx Laboratories position as of Q1 2024 after selling out during the quarter.
  • Capital International sold 22,771 Idexx Laboratories shares in Q1 2024, an estimated $12.6M.
  • Capital International first reported a position in Idexx Laboratories in Q4 2017 and held it in 25 quarters.
  • Capital International's Idexx Laboratories position peaked at $15.2M in Q4 2021.
  • 1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on Capital International's 13F filing for Q1 2024, filed 14 May 2024.